Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Stem Cells Translational Medicine|November 1, 2022
Cellular and Molecular Targets of Extracellular Vesicles from Mesenchymal Stem/Stromal Cells in Rheumatoid ArthritisMaría José Alcaraz, María Isabel Guillén
Cells|January 8, 2020
Extracellular Vesicles from Mesenchymal Stem Cells as Novel Treatments for Musculoskeletal DiseasesMaría José Alcaraz, Alvaro Compañ, María Isabel Guillén
Methods in Molecular Biology (Clifton, N.J.)|March 9, 2021
Evaluation of Extracellular Vesicles from Adipose Tissue-Derived Mesenchymal Stem Cells in Primary Human Chondrocytes from Patients with OsteoarthritisMaría Isabel Guillén, Alvaro Compañ, María José Alcaraz
Biochemical Pharmacology|March 4, 2019
Emerging therapeutic agents in osteoarthritisMaría José Alcaraz, María Isabel Guillén, María Luisa Ferrándiz
International Review of Cell and Molecular Biology|July 23, 2025
Clinical development complexity of TGF-β inhibition: From fibrosis to cancer immunotherapyGabriel Gallo-Oller, María Isabel Guillén-Antonini, Javier Dotor
Biochemical Pharmacology|March 12, 2003
Heme oxygenase-1 induction and regulation in unstimulated mouse peritoneal macrophagesAna María Vicente, María Isabel Guillén, María José Alcaraz
International Journal of Molecular Sciences|May 14, 2022
Connection between Mesenchymal Stem Cells Therapy and Osteoclasts in OsteoarthritisLidia Ibáñez, Paloma Guillem-Llobat, Marta Marín, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 17, 2003
Beneficial effects of heme oxygenase-1 up-regulation in the development of experimental inflammation induced by zymosanAna María Vicente, María Isabel Guillén, Auïda Habib, et al.
International Journal of Molecular Sciences|February 12, 2021
Extracellular Vesicles Do Not Mediate the Anti-Inflammatory Actions of Mouse-Derived Adipose Tissue Mesenchymal Stem Cells SecretomeMaría Carmen Carceller, María Isabel Guillén, María Luisa Gil, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 16, 2008
The carbon monoxide-releasing molecule tricarbonyldichlororuthenium(II) dimer protects human osteoarthritic chondrocytes and cartilage from the catabolic actions of interleukin-1betaJavier Megías, María Isabel Guillén, Antonio Bru, et al.
Pageof 2